Socio-Clinical Factors Associated With Self-Management in Parkinson's Disease
1 other identifier
observational
90
1 country
1
Brief Summary
Self-management focuses on the behaviors that people with chronic disease use in order to maintain and improve their health and well-being and includes aspects such as medical and lifestyle management. Parkinson's disease (PD) is a chronic, progressive, incurable neurodegenerative disorder that affects motor and non-motor function. Engagement in self-management behaviors and high activation may be effective tools in fighting the long-lasting burden of the disease. The goal of the current study was to explore socio-clinical factors that associate with specific self-management behaviors and patient activation among patients with Parkinson's disease. PwP were recruited from the Movement Disorders Institute, Department of Neurology, Rambam Health Care Campus. Eligible patients were assessed for cognitive status and filled questionnaires regarding socio-clinical factors included age, gender, severity of motor and non -motor symptoms, family and social support. Data about the comorbidities were retrieved from electronic medical records
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 30, 2021
CompletedFirst Posted
Study publicly available on registry
January 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2022
CompletedMay 11, 2023
May 1, 2023
2.9 years
December 30, 2021
May 9, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Patient's Activation Measure (PAM-13®️, Insignia Health)
Patient Activation Measure (PAM) score. Patient activation' describes the skills, confidence and knowledge a person has in managing her/his own health and health care. It consists of 13 statements rated on a four-point Likert scale of level of agreement. The PAM-13 score is transformed into a 0-100 continuous scale according to a licensed conversion table (Insignia Health)
through study completion, an average of 1 year
International Physical Activity Questionnaire- IPAQ-SHORT
This questionnaire asks individuals to assess the number of days and amount of time they spent in the last 7 days in four categories: 1) vigorous activity (heavy lifting, aerobics, fast bicycling), 2) moderate activity (light lifting, moderate bicycling), 3) walking (at least 10 minutes), 4) sitting (watching TV, reading). Total physical activity is calculated as the sum of Walking + Moderate + Vigorous metabolic equivalent (MET) minutes/week scores.
through study completion, an average of 1 year
Utilization of rehabilitative treatments
Participants reported about whether and how frequently they utilize physical therapy, occupational therapy, and speech and language pathology treatments
Through study completion, an average of 1 year
Interventions
There is no intervention in this study
Eligibility Criteria
Patients with PD who are treated in the Movement Disorders Institute, Department of Neurology, Rambam Health Care Campus.
You may qualify if:
- Diagnosis of PD
- Age \> 18
You may not qualify if:
- Mini Mental State Exam\<20
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Haifalead
- Rambam Health Care Campuscollaborator
Study Sites (1)
Galit Yogev-Seligmann
Haifa, Please Select..., 3498838, Israel
Related Publications (1)
Duvdevani M, Yogev-Seligmann G, Schlesinger I, Nassar M, Erich I, Hadad R, Kafri M. Association of health behaviors with function and health-related quality of life among patients with Parkinson's disease. Isr J Health Policy Res. 2024 Jan 3;13(1):2. doi: 10.1186/s13584-023-00588-3.
PMID: 38173041DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
December 30, 2021
First Posted
January 27, 2022
Study Start
May 1, 2019
Primary Completion
March 28, 2022
Study Completion
March 30, 2022
Last Updated
May 11, 2023
Record last verified: 2023-05